Join our community of smart investors

AMS recovers as elective surgeries rise

The surgical and woundcare has reported improved volumes as health priorities change
AMS recovers as elective surgeries rise


  • Elective surgery levels improve, albeit gradually
  • An increase in R&D as approval processes gather pace

The main half-year reporting season has highlighted the contrasting impact of the pandemic, both on individual companies and sectors. By midway through 2020, Advanced Medical Solutions (AMS) had seen demand for its product range fall by around a fifth due to a sharp decline in elective surgeries performed by the NHS.

To continue reading...
Join our Community of Smart Investors
  • Independent full-length company analysis
  • Actionable investment ideas and recommendations
  • Expert investment tools and data
  • Stock screens from Algy Hall
Have an account? Sign in